Navigation Links
Cardium Reports on Transdel Transaction
Date:7/28/2011

SAN DIEGO, July 28, 2011 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today provided an update regarding its plan to acquire substantially all of Transdel Pharmaceuticals' business assets in connection with a proposed asset purchase under Chapter 11 of the U.S. Bankruptcy Code. As described on June 27, 2011, the completion of such an asset purchase is subject to a number of conditions, including approval of the bankruptcy court.  In an effort to expedite the proposed transaction, Transdel and Cardium asked the bankruptcy court to approve the sale under Section 363 of the Bankruptcy Code, which does not require the filing of a plan subject to approval of creditors.  In support of that request, Transdel's major creditor had filed a declaration in favor of Cardium's proposed purchase, but subsequently opposed the sale, potentially to offer a plan of its own, which led to the court denying Transdel's motion for expedited approval.

(Logo:  http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)

"Cardium's business model is focused on the opportunistic acquisition of assets having the potential for significant upside valuation," noted Christopher J. Reinhard, Chairman and Chief Executive Officer of Cardium.  "In that regard, we will continue to evaluate our options with respect to this and other business opportunities under consideration, consistent with our strategy of acquiring businesses with favorable valuations and clearly defined pathways to commercialization or other monetization," added Mr. Reinhard.

About Cardium

Cardium is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to commer
'/>"/>

SOURCE Cardium Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cardium Announces Market Introduction of New Alena™ Clinical Strength Carb Blocker to Expand the MedPodium Healthy Lifestyle Product Line
2. Cardium Announces Plans to Acquire Transdel Pharmaceuticals Phase 3 Topical Analgesic and Cosmeceutical Business Assets
3. Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation
4. Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones
5. Cardium to Present at OneMedForum San Francisco 2011 Conference
6. Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process
7. Cardium Reports on Fourth Quarter and Year-End 2009 Financial Results and Recent Developments
8. Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development
9. Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
10. Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers
11. Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... -- DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology ... and education markets, announced today that has been no ... disclosed or, to its knowledge, any other reason to ... "We have noticed unusual price and volume increases for ... Steve Barbee , CEO of DigiPath. "While we ...
(Date:7/30/2014)...  Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a ... expertise in opioid antagonists, announced today that it ... international research and development foundation. The ... initiatives, including those addressing health issues. Lightlake has ... of naloxone that could widely expand its availability ...
(Date:7/30/2014)... , July 30, 2014   Bluegrass ... focused on innovating lifesaving devices and methods for ... million in Series A financing, which was led ... from the deal will allow Bluegrass Vascular to ... Catheter System, enhance manufacturing capabilities, and proceed with ...
Breaking Medicine Technology:DigiPath No New Corporate Developments 2Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 2Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 3Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led By Targeted Technology Funds 2
... WASHINGTON, Nov. 1 Multiple myeloma is one,of the ... U.S., but,survival rates have risen dramatically over the past ... to new types of drugs,and aggressive therapeutic interventions such ... studies prepublished online in Blood, the,official journal of the ...
... IRVINE, Calif., Nov. 1 IDM Pharma, Inc.,(Nasdaq: ... data,from the Phase 3 mifamurtide (L-MTP-PE) clinical trial (INT-0133). ... funded cooperative,group study conducted by the Children,s Oncology Group ... of patients originally treated in the Phase,3 trial. The ...
Cached Medicine Technology:Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies 2Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies 3Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies 4IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients 2IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients 3IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients 4IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients 5IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients 6
(Date:7/31/2014)... CA (PRWEB) July 31, 2014 ... in the specialty and general lighting marketplaces, today ... Retrofit kits. These will allow users to transform ... LED fixtures within minutes. , USHIO America’s Uphoria ... and 6-inch downlight cans, allowing the user to ...
(Date:7/31/2014)... 2014 Thanks to its mildly ... has long been used as a medium for ... monk fruit. However consistent, dependable sourcing of erythritol ... meet food and beverage manufacturers’ increasing needs for ... launched GMO-free ErysweetTM Erythritol. , “Erysweet is ...
(Date:7/30/2014)... Vail and Beaver Creek, Colo., skiers have ... “Blind Skier.” Those skiers and guides are enjoying time ... , a non-profit organization founded in 2001 that matches ... for snow sport opportunities. Visually impaired skiers and snowboarders ... pick up an application to participate in the program ...
(Date:7/30/2014)... (PRWEB) July 31, 2014 CareSource, a ... A. Fecher President and CEO, Wright-Patt Credit Union, to ... is a foremost financial CEO with an extensive background ... of lending and later chief operating officer at Wright-Patt ... has led the Beavercreek-based Wright-Patt Credit Union that has ...
(Date:7/30/2014)... returning National Guard soldiers were more likely to ... life setbacks, including job loss, legal problems, divorce, ... military families. Results of the study by researchers ... are published online in the American Journal ... a major concern for reservists returning home. Nearly ...
Breaking Medicine News(10 mins):Health News:USHIO America Introduces Uphoria™ LED Downlight Retrofit Kits 2Health News:Steviva Ingredients Launches Erysweet Erythritol 2Health News:Colorado Non-Profit Foresight Ski Guides Seeking Applications for Blind and Visually Impaired Skiers and Guides for Vail Ski Season 2Health News:Vets' alcohol problems linked to stress on the home front 2
... functions early in myogenesis to help stem cells proliferate in ... Reserve University. The study appears online Jan. 4 in the ... MyoD is a transcription factor that activates muscle-specific genes ... fibers. But MyoD is also expressed at an earlier stage ...
... have pinpointed the prime factors identifying which elderly persons ... The researchers, led by Jeffrey M. Lyness, M.D., ... findings in an article in the December issue of ... treatments for people in the high-risk group hold promise ...
... camps, , THURSDAY, Dec. 31 (HealthDay News) -- Forget ... camps designed for people and their pets are ... one-stop fitness program. , During the 60-minute classes, campers are ... balance and cardiovascular challenges, as well as dog obedience drills. ...
... ANGELES, Dec. 31 Numbers are not just statistics. Sometimes they ... preceding century when lives became daily body counts in televised wars, ... is certainly not the only organization whose staff have worked 24/7 ... staffs of all humanitarian groups and those individual human beings who ...
... Calorie Control ... be leading the way in 2010, according to the Calorie Control Council. Recessionistas will ... ... -- Recessionistas and calorie counters will be leading the way in 2010, according to ...
... , WASHINGTON, Dec. 31 The following ... Tobacco-Free Kids: , (Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) , ... for health when it becomes the first major tobacco-growing state ... and bars. This new law will protect the right ...
Cached Medicine News:Health News:Study identifies those elderly most at risk for major depression 2Health News:Add Some Woof! to Your Workout 2Health News:Add Some Woof! to Your Workout 3Health News:Narconon Salutes Its 1,200 Staff Worldwide on 13,000 Lives Saved This Last Decade 2Health News:Narconon Salutes Its 1,200 Staff Worldwide on 13,000 Lives Saved This Last Decade 3Health News:“Recessionistas” and Calorie Counters Lead 2010 Health Trends 2Health News:“Recessionistas” and Calorie Counters Lead 2010 Health Trends 3Health News:North Carolina Goes Smoke-Free on Jan. 2 in Historic Step for Health 2Health News:North Carolina Goes Smoke-Free on Jan. 2 in Historic Step for Health 3
Semi-Automated Chemistry Analyzer with model screen master. The Screen Master incorporates many powerful features in one compact unit. Useful for biochemical investigations, enzymatic, immunoturbidi...
... Geometric Data Hemastainer. Formulated to ... quality control tested on human ... staining and absence of precipitate. ... a minimum of eight hours ...
... Unique molecular suspension in methanol for ... chromosome, and histology smears. Our special ... rapidly penetrates cellular elements producing unequaled ... detail and unexcelled brilliance in the ...
Wright-Giemsa Stain Solutions...
Medicine Products: